Medical Science Liaison
AbbottFull Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
Key technologies and capabilities for this role
Common questions about this position
The role is field-based in the North Florida territory, primarily supporting Orlando and Jacksonville, and the company is considering candidates residing in that region.
Candidates need an advanced scientific or medical degree such as PhD, PharmD, MD, MSN, or BSN, with a basic understanding of oncology required and molecular testing strongly preferred. Preferred qualifications include 1+ years of MSL experience in diagnostics, biotech, or pharmaceutical industries.
Required skills include a fundamental understanding of molecular oncology, existing KOL relationships in oncology, working knowledge of genomic LDT and regulations like CLIA-88’ and CAP, public speaking skills, exceptional interpersonal communication, and the ability to travel up to 50%.
This information is not specified in the job description.
A strong candidate will have an advanced degree in a scientific or medical field, experience in oncology and molecular testing, existing KOL relationships, MSL experience in diagnostics or biotech, and excellent communication and public speaking skills.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.